There’s a difference between building an MSO and building a movement, and Allied OMS isn’t in this game for a participation trophy.
While most folks are still trying to paste clinical care to an Excel sheet and call it “strategy,” Allied OMS has been quietly running the kind of blueprint that makes PE firms perk up and surgeons lean in. This week? That quiet just turned into a roar.
A strategic growth investment from 65 Equity Partners, with Everberg Capital rolling in as co-pilot, marks Allied OMS’ first institutional capital raise. But make no mistake, this isn’t a typical check-drop. It’s a signal. A bet. A minority stake with major implications. For an organization that’s already tripled in size since 2022, pushed past 50 locations, and crossed $140M in revenue without selling its clinical soul, it’s not about the capital. It’s about the caliber.
Built by surgeons, for surgeons, Allied OMS has turned “doctor-led” from marketing buzzword into power structure. Co-founders Daniel Hosler (CEO), Ryan Graham (COO), Dr. David Kostohryz, Jr., Dr. Jonathon S. Jundt, and Dr. Greg Scheideman didn’t just write the operating manual, they operated on the manual itself. These aren’t front-office founders, they’re in the trenches and on the board, where 75% of seats belong to doctors and 100% of management committees answer to the folks actually holding the scalpel.
They scaled not by handing out incentives, but by handing over ownership. The Doctor Equity™ model doesn’t just cut checks, it cuts surgeons in. That’s the secret sauce behind 20% profit lifts for new practices and 10-point margin jumps network-wide. It’s the difference between a suit managing from above and a surgeon leading from within.
The oralsurgery game is a $10B beast in a $40B jungle, and most of it’s still wandering the forest. Allied OMS isn’t just carving out territory, it’s setting up a clinical democracy with a financial backbone. And they’re not stopping at growth. They’re scaling de novo sites, recruiting elite practitioners, and deepening their presence across the U.S., all while holding the line on clinical independence and operational integrity.
So when the news hits that 65 Equity Partners and Everberg Capital have joined the table, don’t mistake it for a handshake. This is alignment. This is acceleration. This is what it looks like when operational excellence meets surgical precision, and doesn’t blink.
